Skip to main content
Equibles
ASMB logo

ASMB · Assembly Biosciences, Inc.

Track ASMB — free

Use ASMB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ASMB

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$32.95 +3.00 (+10.02%) At close · Aug 14
Market Cap
$670.88M
Shares
20.36M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$32.95 Open$30.08 Day$29.79–33.17 52W close$20.55–38.50 Avg vol 30d177K Short int2.3M · 11.5% float · 15.8d Short vol40% Last earningsApr 17, 2026 DataFeb 2024–Aug 2026 Filing10-Q · Aug 13

Raw chart and full-history price indicators begin at the captured split on Feb 12, 2024; bars on opposite sides are not compared.

Up next

Next earnings call
Aug 22, 2026 Est · unconfirmed · in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +13%
above
Price vs 50-day avg +27%
above
RSI (14) 76
overbought
MACD trend Positive
52-week position 69%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Neutral
1-month return +23%
trailing
6-month return +10%
trailing
YTD return −3%
this year
Relative strength −4%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $26 › 200d $29 — 200d above 50d
Institutional flow Accumulating
+23% holders QoQ · +33 funds added
Insider flow Distributing
Net -$674 over 90 days · 100% sells
Short interest Rising
11.47% of float · ▲ +1.0% MoM · 15.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
92 holders — near 3-yr high, broad support
Squeeze score 93
high risk · 0–100
Fundamentals
Strong
Revenue growth +154%
Y/Y
EPS growth +92%
Y/Y
Free cash flow $-41.2M
Balance sheet $58.0M
net cash
Quant / Vol
risk profile
Very High
Volatility 58%
annualized · 1-yr
Max drawdown −42%
past year
ATR 4.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+13% Bullish
Price vs 50-day avg
+27% Bullish
RSI (14)
76 Bearish
MACD trend
Positive Bullish
52-week position
69% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $26 › 200d $29 — 200d above 50d
Institutional flow Accumulating
+23% holders QoQ · +33 funds added
Insider flow Distributing
Net -$674 over 90 days · 100% sells
Short interest Rising
11.47% of float · ▲ +1.0% MoM · 15.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
92 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $21 Now $33 · 69% Range high $39
vs 200-day avg +13% vs 50-day avg +27%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ASMB
Assembly Biosciences, Inc.
this stock
$670.88M -3.1% +153.5% — 11.5%
ONC
BeOne Medicines Ltd.
 $513.62B +14.4% +22179.2% 789.7 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $128.19B +11.6% +46.2% 29.5 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
 $82.72B +4.1% +20.8% 19.9 3.3%
ARGX
Argenx SE
 $52.94B +1.2% — — 2.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
92
% held
90.2%
Net QoQ
+4.8M sh
Top holder
GILEAD SCIENCES, INC.
Held Float
View
Held by Funds
Fund positions
31
View
Short & Settlement
Short Interest Rising
Shares short
2.3M
Days to cover
15.8d
Change
+23.7K sh
View
Short Volume
Short vol %
40%
As of
Aug 14, 2026
Short Total
View
Fails to Deliver
FTD shares
6
Value
$174
As of
Jul 8, 2026
View
Off-Exchange
Off-exchange %
37.7%
Week of
Jul 6, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$674
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
Christopher L. Jacobs
Amount
$1.0K–$15.0K
Traded
Jan 4, 2021
View
Financials
Financials
Revenue (FY)
$72.3M
Net income (FY)
$-6.1M
EPS diluted
$-0.55
View
Filings
SEC Filings
Latest
8-K/A
Filed
Aug 14, 2026
This year
14
View
Proposed Sales
Value
$1.6K
Shares
1.9K
Filed
Oct 3, 2023
View
Earnings & Events
Earnings Calls
Last call
Jun 8, 2026
View
Investor Relations
Latest news
Assembly Biosciences Reports Seco…
Published
Aug 13, 2026
View

Performance

Raw-price comparisons begin at the captured split on Feb 12, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
ASMB +23.5% +22.9% +10.0% +31.2% -3.1%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY +23.1% +18.5% -3.8% +27.3% -17.0%
Key facts CIK 1426800 CUSIP 045396207 13F (30d) 95 filings 93 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)